Patent classifications
C07D277/72
Controlled release materials for anti-corrosion agents
Corrosion inhibitor materials are provided that release active corrosion inhibitor compounds when they are most neededin response to changes in conditions, including acid or basic pH, that cause corrosion or occur at the early stages of corrosion. The materials comprise particles that can be dispersed in paints and coatings for metals. The particles in some cases include ionic water-soluble anti-corrosion agents complexed to oppositely charged surfactants and entrapped in silica oxide or metal oxide gels.
Controlled release materials for anti-corrosion agents
Corrosion inhibitor materials are provided that release active corrosion inhibitor compounds when they are most neededin response to changes in conditions, including acid or basic pH, that cause corrosion or occur at the early stages of corrosion. The materials comprise particles that can be dispersed in paints and coatings for metals. The particles in some cases include ionic water-soluble anti-corrosion agents complexed to oppositely charged surfactants and entrapped in silica oxide or metal oxide gels.
RUBBER - FORMING ADDITIVES FROM BIOMASS THROUGH SYNGAS PRODUCTION
A method of forming a tire-forming additive includes converting biomass to syngas; synthesizing at least one of benzene and an alkyl-substituted benzene, from carbon monoxide and hydrogen in the syngas; synthesizing at least one of aniline and an alkyl-substituted aniline from the at least one of the benzene and the alkyl-substituted benzene; and synthesizing a tire-forming additive from the at least one of the aniline and the alkyl-substituted aniline, the tire-forming additive being selected from the group consisting of an anti-degradant, a vulcanization accelerator, and combinations thereof.
RUBBER - FORMING ADDITIVES FROM END OF LIFE TIRES THROUGH SYNGAS PRODUCTION
A method of forming a tire-forming additive includes converting shredded tires/tire components to syngas; synthesizing at least one of benzene and an alkyl-substituted benzene, from carbon monoxide and hydrogen in the syngas; synthesizing at least one of aniline and an alkyl-substituted aniline from the at least one of the benzene and the alkyl-substituted benzene; and synthesizing a tire-forming additive from the at least one of the aniline and the alkyl-substituted aniline, the tire-forming additive being selected from the group consisting of an anti-degradant, a vulcanization accelerator, and combinations thereof.
RUBBER - FORMING ADDITIVES FROM END OF LIFE TIRES THROUGH SYNGAS PRODUCTION
A method of forming a tire-forming additive includes converting shredded tires/tire components to syngas; synthesizing at least one of benzene and an alkyl-substituted benzene, from carbon monoxide and hydrogen in the syngas; synthesizing at least one of aniline and an alkyl-substituted aniline from the at least one of the benzene and the alkyl-substituted benzene; and synthesizing a tire-forming additive from the at least one of the aniline and the alkyl-substituted aniline, the tire-forming additive being selected from the group consisting of an anti-degradant, a vulcanization accelerator, and combinations thereof.
Compounds for modulating integrin CD11B/CD18
The application describes an assay for the identification of small molecule modulators of integrin CD11b/CD18 and small molecules capable of modulating activity of this receptor. Such compounds may be used in certain embodiments for treating a disease or condition selected from inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, bullous pemphigoid, neonatal obstructive nephropathy, and cardiovascular disease, or in other embodiments for the treatment of a disease or condition selected from immune deficiency, acquired immune deficiency syndrome (AIDS), myeloperoxidase deficiency, Wiskott-Aldrich syndrome, chronic granulomatous disease, hyper-IgM syndromes, leukocyte adhesion deficiency, Chediak-Higashi syndrome, and severe combined immunodeficiency.
Compounds for modulating integrin CD11B/CD18
The application describes an assay for the identification of small molecule modulators of integrin CD11b/CD18 and small molecules capable of modulating activity of this receptor. Such compounds may be used in certain embodiments for treating a disease or condition selected from inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, bullous pemphigoid, neonatal obstructive nephropathy, and cardiovascular disease, or in other embodiments for the treatment of a disease or condition selected from immune deficiency, acquired immune deficiency syndrome (AIDS), myeloperoxidase deficiency, Wiskott-Aldrich syndrome, chronic granulomatous disease, hyper-IgM syndromes, leukocyte adhesion deficiency, Chediak-Higashi syndrome, and severe combined immunodeficiency.
Method for preparing 2-mercaptobenzothiazole
A method for preparing 2-mercaptobenzothiazole where the aniline method is adopted to perform reaction in the presence of a catalyst, and the catalyst includes sulfonic acid type imidazolium ionic liquid. The sulfonic acid type imidazolium ionic liquid is a type of acidic functionalized ionic liquid, and has the advantages of both a solid acid and a liquid acid. The sulfonic acid type imidazolium ionic liquid is adopted as an active ingredient of the catalyst, and may remarkably improve a conversion rate of the reaction raw materials and increase a yield of the 2-mercaptobenzothiazole. Meanwhile, due to the characteristics of high catalytic activity, no volatilization, low corrosion, high thermal stability and the like of the 2-mercaptobenzothiazole, the preparation method also has the comprehensive advantages of simple process, low cost, low tar yield, high environment friendliness and the like.
Method for preparing 2-mercaptobenzothiazole
A method for preparing 2-mercaptobenzothiazole where the aniline method is adopted to perform reaction in the presence of a catalyst, and the catalyst includes sulfonic acid type imidazolium ionic liquid. The sulfonic acid type imidazolium ionic liquid is a type of acidic functionalized ionic liquid, and has the advantages of both a solid acid and a liquid acid. The sulfonic acid type imidazolium ionic liquid is adopted as an active ingredient of the catalyst, and may remarkably improve a conversion rate of the reaction raw materials and increase a yield of the 2-mercaptobenzothiazole. Meanwhile, due to the characteristics of high catalytic activity, no volatilization, low corrosion, high thermal stability and the like of the 2-mercaptobenzothiazole, the preparation method also has the comprehensive advantages of simple process, low cost, low tar yield, high environment friendliness and the like.
METHOD FOR PREPARING 2-MERCAPTOBENZOTHIAZOLE
A method for preparing 2-mercaptobenzothiazole where the aniline method is adopted to perform reaction in the presence of a catalyst, and the catalyst includes sulfonic acid type imidazolium ionic liquid. The sulfonic acid type imidazolium ionic liquid is a type of acidic functionalized ionic liquid, and has the advantages of both a solid acid and a liquid acid. The sulfonic acid type imidazolium ionic liquid is adopted as an active ingredient of the catalyst, and may remarkably improve a conversion rate of the reaction raw materials and increase a yield of the 2-mercaptobenzothiazole. Meanwhile, due to the characteristics of high catalytic activity, no volatilization, low corrosion, high thermal stability and the like of the 2-mercaptobenzothiazole, the preparation method also has the comprehensive advantages of simple process, low cost, low tar yield, high environment friendliness and the like.